Seema Khaneja MD
Updated on: October 11, 2024 5:07 am GMT
Kourtney Kardashian Barker’s supplement brand, Lemme, has entered the burgeoning weight management market with the launch of Lemme GLP-1 Daily, a product designed to provide an all-natural alternative to GLP-1 agonists like Ozempic and Wegovy. Set to be officially available starting September 16, this new supplement is positioned as a way to boost the body’s natural GLP-1 hormone levels, which may lead to reduced hunger and improved insulin sensitivity.
Details of Lemme GLP-1 Daily
Priced at $72 per month for subscribers, or $90 for a one-time purchase, Lemme GLP-1 Daily is marketed as a solution for healthy weight management. Unlike synthetic GLP-1 medications, this product does not contain any artificial hormones. Instead, it utilizes natural ingredients believed to support the body’s own GLP-1 production and aid in appetite control.
The supplement combines three key ingredients:
- Eriomin: A patented lemon extract primarily composed of eriocitrin, which is claimed to have potential positive effects on blood sugar and GLP-1 levels.
- Supresa: A saffron extract that has been linked in some research to reductions in snacking behavior. However, the evidence supporting significant weight loss from saffron is limited.
- Morosil: An extract from blood oranges that some studies suggest may contribute to lower BMI when combined with dietary and exercise recommendations.
Market Reaction and Context
The emergence of Lemme GLP-1 Daily reflects a larger trend where various brands are looking to capitalize on the popularity of the GLP-1 class of medications. This class, including drugs like Ozempic and Wegovy, has transformed the weight loss industry, which is already estimated to be worth around $76 billion. These drugs mimic the GLP-1 hormone, assisting users by making them feel fuller, thus aiding in weight loss.
However, as restrictive and highly regulated as pharmaceutical options like Ozempic are, dietary supplements, such as Lemme GLP-1 Daily, do not receive the same level of scrutiny. The U.S. Food and Drug Administration (FDA) does not approve dietary supplements, meaning that the responsibility for the safety and efficacy of these products falls on the manufacturers.
Scientific Support for Ingredients
While Kardashian’s company touts that the ingredients in Lemme GLP-1 Daily have been human-tested, the findings often stem from small-scale studies that lack rigorous independent verification.
Eriomin
Research on Eriomin suggests it may help improve blood glucose levels and enhance GLP-1 production. A study conducted with 45 participants over 12 weeks indicated those taking Eriomin experienced a decrease in blood glucose and an increase in GLP-1 levels compared to a placebo. However, the results did not demonstrate a significant impact on body weight.
Supresa
Regarding Supresa, the saffron extract, limited evidence exists to suggest its effectiveness in promoting weight loss. An 8-week study found that participants taking saffron reported less snacking compared to those on a placebo. Yet, evidence from a meta-analysis of previous studies showed that while there might be some decreases in waist and hip measurements, these changes lacked statistical significance.
Morosil
Morosil—a patented blood orange extract—showed promise in studies funded by its patent holder. Participants who ingested this ingredient had better outcomes in terms of BMI compared to those taking a placebo, although they also adhered to a defined exercise and calorie-restricted diet during the trial.
Considerations for Potential Users
With weight management solutions evolving rapidly, it is crucial for consumers to approach new products like Lemme GLP-1 Daily with caution. The absence of significant evidence supporting substantial weight loss and the lack of independent clinical trials raises questions about the effectiveness of such supplements. Health experts caution individuals to prioritize established weight loss methods, such as balanced nutrition and physical activity, rather than relying solely on supplements.
As Kourtney Kardashian Barker launches this product, she’s not alone in her venture; several brands have surfaced to provide complementary products catering to the growing interest in GLP-1 treatments. Companies like Noom and Weight Watchers have adapted their programs to incorporate GLP-1 medications, signaling a shift in how weight management is approached.
Conclusion
The launch of Lemme GLP-1 Daily shows how popular weight management supplements are becoming. It’s important for people to know how well these products work and if they are safe to use. Many people are looking for help on their weight loss journeys, but it’s still crucial to compare these supplements with methods that are supported by science for staying healthy and well.
